Literature DB >> 2129964

Revised EEG coma scale in diffuse acute head injuries in adults.

V M Synek1.   

Abstract

The validity of a recently published EEG grading scale applied to patients with acute head injuries has been investigated. This scale is based on 15 individual grades and subdivisions and 3 major groups: 4 patterns are benign regarding survival, 4 are of uncertain significance and 7 patterns are prognostically malignant. The evaluation was performed in 90 adult patients with acute head injuries in whom EEGs obtained during the 36 hours after the injury were evaluated retrospectively without knowing the clinical details or the outcome. By employing previously reported definitions it was possible to allocate EEG abnormalities in all cases. The assumption was made that at the time of the EEG investigation the impact of the head injury on cerebral function was already established. All patients displaying 'benign' patterns survived. 'Uncertain' patterns were the most common ones and in patients with these the reactivity of EEG activity was more important for prognosis than the quality of the background activity. All but 3 of the patients with a 'malignant' pattern died, and the survivors remained in a vegetative state. There was a correlation between the EEG findings and the Glasgow Coma Scale score on admission and also with the results of computerized tomography of the brain. In those patients who died there was no significant relationship between EEG signs and autopsy findings. Repeated EEGs are always desirable with severe head injuries but the results of this study suggest that useful prognostic information can be obtained from an EEG recorded within 36 hours after the head trauma.

Entities:  

Mesh:

Year:  1990        PMID: 2129964

Source DB:  PubMed          Journal:  Clin Exp Neurol        ISSN: 0196-6383


  8 in total

1.  The Prognostic Value of 48-h Continuous EEG During Therapeutic Hypothermia After Cardiac Arrest.

Authors:  Marta Lamartine Monteiro; Fabio Silvio Taccone; Chantal Depondt; Irene Lamanna; Nicolas Gaspard; Noémie Ligot; Nicolas Mavroudakis; Gilles Naeije; Jean-Louis Vincent; Benjamin Legros
Journal:  Neurocrit Care       Date:  2016-04       Impact factor: 3.210

Review 2.  Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM.

Authors:  Jan Claassen; Fabio S Taccone; Peter Horn; Martin Holtkamp; Nino Stocchetti; Mauro Oddo
Journal:  Intensive Care Med       Date:  2013-05-08       Impact factor: 17.440

3.  Association between death and loss of stage N2 sleep features among critically Ill patients with delirium.

Authors:  Melissa P Knauert; Emily J Gilmore; Terrence E Murphy; Henry K Yaggi; Peter H Van Ness; Ling Han; Lawrence J Hirsch; Margaret A Pisani
Journal:  J Crit Care       Date:  2018-08-23       Impact factor: 3.425

Review 4.  The Risk of Sleep Disorder Among Persons with Mild Traumatic Brain Injury.

Authors:  Tatyana Mollayeva; Shirin Mollayeva; Angela Colantonio
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

5.  Predictive value of EEG-awakening for behavioral awakening from coma.

Authors:  Xiao-Gang Kang; Feng Yang; Wen Li; Chen Ma; Li Li; Wen Jiang
Journal:  Ann Intensive Care       Date:  2015-12-21       Impact factor: 6.925

Review 6.  Current Opportunities for Clinical Monitoring of Axonal Pathology in Traumatic Brain Injury.

Authors:  Parmenion P Tsitsopoulos; Sami Abu Hamdeh; Niklas Marklund
Journal:  Front Neurol       Date:  2017-11-20       Impact factor: 4.003

7.  Predicting Outcome in Comatose Patients: The Role of EEG Reactivity to Quantifiable Electrical Stimuli.

Authors:  Gang Liu; Yingying Su; Yifei Liu; Mengdi Jiang; Yan Zhang; Yunzhou Zhang; Daiquan Gao
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-03       Impact factor: 2.629

Review 8.  Electroencephalography in delirium assessment: a scoping review.

Authors:  Tim L T Wiegand; Jan Rémi; Konstantinos Dimitriadis
Journal:  BMC Neurol       Date:  2022-03-11       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.